Abstract
A series of novel 1,2,3-triazole linked thiazole-1,2-isoxazole derivatives has been designed, synthesized and characterized by 1H and 13C NMR, and mass spectral analysis. The compounds have been tested for their anticancer activity towards MCF-7 (breast cancer), A549 (lung cancer), Colo-205 (colon cancer), and A2780 (ovarian cancer) by using the MTT method using etoposide as the reference. Most of the tested compounds demonstrate good to moderate activity against all cell lines. The compounds 14b, 14e, 14g, and 14h are characterized by inhibitory activity stronger than that of etoposide.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hutchinson, I., Chua, M.S., Browne, H.L., Trapani, V., Bradshaw, T.D., Westwell, A. D., and Stevens, M.F.G., J. Med. Chem., 2001, vol. 44, p. 1446. https://doi.org/10.1021/jm001104n
Shih, M.H. and Ying, K.F. Bioorg. Med. Chem., 2004, vol. 12, p. 4633. https://doi.org/10.1016/j.bmc.2004.06.033
Mayhoub, A.S., Khaliq, M., and Botting, C., Bioorg. Med. Chem., 2011, vol. 19, p. 3845. https://doi.org/10.1016/j.bmc.2011.04.041
Schade, A.E., Schieven, G.L., Townsend, R., Jankowska, A.M., Susulic, V., Zhang, R., Szpurka, H., Maciejewski, J.P., and Dasatinib, Blood, 2008, vol. 111, p. 1366.
Chao, S., Oh, S., Um, Y., Jung, J.H., Ham, J., Shin, W.S., and Lee, S., Bioorg. Med. Chem. Lett., 2009, vol. 19, p. 382. https://doi.org/10.1016/j.bmcl.2008.11.067
Costa, M.S., Boechat, N., Rangel, E.A., Da Silva, F.D., de Souza, A.M.T., Rodrigues, C.R., Castro, H.C., Junior, I.N., Lourenco, M.C.S., Wardell, S.M.S.V., and Ferreira, V.F. Bioorg. Med. Chem., 2006, vol. 14, p. 8644. https://doi.org/10.1016/j.bmc.2006.08.019
Kumar, K.K., Seenivasan, S.P., Kumar, V., and Das, T.M., Carbohyd. Res., 2011, vol. 346, p. 2084. https://doi.org/10.1016/j.carres.2011.06.028
da Silva, F.D., de Souza, M.C.B.V., Frugulhetti, I.I.P., Castro, H.C., Souza, S.L.D., de Souza, T.M.L., Rodrigues, D.Q., Souza, A.M.T., Abreu, P.A., Passamani, F., Carlos, R.F., and Vitor, F.S. Eur. J. Med. Chem., 2009, vol. 44, p. 373. https://doi.org/10.1016/j.ejmech.2008.02.047
Felder, C.C., Ma, A.L., Liotta, L.A., and Kohn, E.C., J. Pharmacol. Exp. Ther., 1991, vol. 257, p. 967.
Kohn, E.C., Sandeen, M.A., and Liotta, L.A. Cancer Res., 1992, vol. 52, p. 3208.
Wasilenko, W.J., Palad, A.J., Somers, K.D., Blackmore, P.F., Kohn, E.C., Rhim, J.S. Int. J. Cancer, 1996, vol. 68, p. 259. https://doi.org/10.1002/(SICI)1097-0215(19961009)68:2%3C259::AID-IJC20%3E3.0.CO;2-4
Murthy, I.S., Sreenivasulu, R., Alluraiah, G., and Ramesh Raju, R., Russ. J. Gen. Chem., 2019, 89, p. 1718 https://doi.org/10.1134/S1070363219080279
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
No conflict of interest was declared by the authors
Rights and permissions
About this article
Cite this article
Yakantham, T., Sreenivasulu, R., Alluraiah, G. et al. Design, Synthesis, and Anticancer Activity of 1,2,3-Triazole Likned Thiazole-1,2-isoxazole Derivatives. Russ J Gen Chem 89, 2522–2527 (2019). https://doi.org/10.1134/S1070363219120314
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070363219120314